Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential for systemic exposure of
aminolevulinic acid (ALA) and protoporphyrin IX (PpIX) when applied topically under
occlusion, in a maximal use setting in patients with multiple actinic keratoses (AK)
involving the upper extremities.